GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » BioForce Nanosciences Holdings Inc (OTCPK:BFNH) » Definitions » Total Equity

BFNH (BioForce Nanosciences Holdings) Total Equity : $-2.18 Mil (As of Sep. 2024)


View and export this data going back to 2004. Start your Free Trial

What is BioForce Nanosciences Holdings Total Equity?

BioForce Nanosciences Holdings's total equity for the quarter that ended in Sep. 2024 was $-2.18 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

BioForce Nanosciences Holdings Total Equity Historical Data

The historical data trend for BioForce Nanosciences Holdings's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioForce Nanosciences Holdings Total Equity Chart

BioForce Nanosciences Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.05 -0.36 -0.86 -1.35 -1.82

BioForce Nanosciences Holdings Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.71 -1.82 -1.95 -2.06 -2.18

BioForce Nanosciences Holdings Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

BioForce Nanosciences Holdings's Total Equity for the fiscal year that ended in Dec. 2023 is calculated as

Total Equity=Total Assets(Q: Dec. 2023 )-Total Liabilities(Q: Dec. 2023 )
=0.001-1.82
=-1.82

BioForce Nanosciences Holdings's Total Equity for the quarter that ended in Sep. 2024 is calculated as

Total Equity=Total Assets(Q: Sep. 2024 )-Total Liabilities(Q: Sep. 2024 )
=0.002-2.18
=-2.18

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioForce Nanosciences Holdings Total Equity Related Terms

Thank you for viewing the detailed overview of BioForce Nanosciences Holdings's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

BioForce Nanosciences Holdings Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » BioForce Nanosciences Holdings Inc (OTCPK:BFNH) » Definitions » Total Equity
Comparable Companies
SOWG UMEWF FARM ATPC LFVN NAII ZHYBF PLAG NXMH FTLF XSWX:NESN KHC XPAR:BN GIS NSE:NESTLEIND SHSE:603288 SZSE:300999 SHSE:600887 LSE:ABF MEX:BIMBOA
Traded in Other Exchanges
N/A
Address
2020 General Booth Boulevard, Suite 230, Virginia Beach, VA, USA, 23454
Website
https://www.bioforceeclipse.com
BioForce Nanosciences Holdings Inc is a provider of natural vitamins, minerals, and other nutritional supplements, powders, and beverages. It markets its products through social media and telemarketing.
Executives
Richard Kaiser Kaiser director, 10 percent owner, officer: Secretary/Acting CFO 3419 VIRGINIA BEACH BLVD, UNIT 252, VIRGINIA BEACH VA 23452
Merle Ferguson director, 10 percent owner, officer: CEO/President/Treasurer 2020 GENERAL BOOTH BLVD., SUITE 230, VIRGINIA BEACH VA 23454
Susan Donohue 10 percent owner 19001 S. RICHFIELD AVE, #102, GREEN VALLEY AZ 85614
Michael D Dunham director 12000 W PARK PL, EFFECTIVE MANAGEMENT SYSTEMS INC, MILWAUKEE WI 53224
Gregory D Brown officer: Chief Financial Officer BIOFORCE NANOSCIENCES HOLDINGS, INC., 1615 GOLDEN ASPEN DRIVE - SUITE 101, AMES IA 50010-8098
Kerry M Frey officer: Chief Operating Officer BIOFORCE NANOSCIENCES HOLDINGS, INC., 1615 GOLDEN ASPEN DRIVE - SUITE 101, AMES IA 50010
Eric Henderson director, 10 percent owner BIOFORCE NANOSCIENCES HOLDINGS, INC., 1615 GOLDEN ASPEN DRIVE, SUITE 101, AMES IA 50010
Lawrence Marshall Gold director 830 MENLO AVENUE, SUITE 100, MENLO PARK CA 94025
Jean-jacques Sunier director BIOFORCE NANOSCIENCES HOLDINGS, INC., 1615 GOLDEN ASPEN DRIVE, SUITE 101, AMES IA 50010
Societe Generale Asset Management Alternative Investments 10 percent owner 170, PLACE HENRI REGNAULT, LADEFENSE, PARIS I0 92043
Ed Cowle 10 percent owner 6 EAST 45TH ST., SUITE 1000, NEW YORK NY 10017
H Deworth Williams 10 percent owner 2681 EAST PARLEYS WAY, SUITE #204, SALT LAKE CITY UT 84109
Carter Robert P Iii 10 percent owner 25 RADCLIFFE DRIVE, VOORHEES NJ 08043
Harvey N Kaye 10 percent owner 190 NW SPANISH RIVER BLVD., SUITE 101, BOCA RATON FL 33431

BioForce Nanosciences Holdings Headlines

No Headlines